BioPharm International - September 2023

BioPharm International - September 2023

Issue link: https://www.e-digitaleditions.com/i/1507932

Contents of this Issue

Navigation

Page 12 of 30

Download our white paper: S T E R I LE I N J E C TA BLE | LYOP H I L I Z AT ION | OP H T H A L M IC | S T E R I LE A N D NON - S T E R I LE T OP IC A L A N D L IQU I D At Jubilant HollisterStier, we're big enough to handle your fill finish, but small enough to care. Whether you're a major pharmaceutical company seeking high-speed sterile filling or an emerging biotech with clinical trial fill finish needs, we're ready to serve you. We've invested millions in our North American facilities, increasing sterile injectable capacity 50% and drug production capacity over 100%. Our large-scale capabilities are matched by effective, personalized project management. Get the best of both worlds. Experience Jubilant HollisterStier. We handle it all, from fill to finish. We handle it all, from fill to finish. Learn about large-scale ophthalmic production. jublhs.com From big pharma to emerging biotech

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - September 2023 - BioPharm International - September 2023